Exporter

EN
FR
Tiotropium bromide
Statut de médicament essentiel
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
Codes ATC: R03BB04
Indication
Chronic obstructive pulmonary disease Code ICD11: CA22
INN
Tiotropium bromide
Type de médicament
Chemical agent
Type de liste
Liste de base
Formulations
Respiratory > Inhalation > powder: 18 µg in capsule
Respiratory > Inhalation > solution: 1.25 µg per actuation in soft mist inhaler ; 2.5 µg per actuation in soft mist inhaler
Historique des statuts LME
Ajouté pour la première fois en 2019 (TRS 1021)
Modifié en 2021 (TRS 1035)
Modifié en 2025 (TRS 1064)
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
aclidinium (Codes ATC: R03BB05)
glycopyrronium (Codes ATC: R03BB06)
umeclidinium (Codes ATC: R03BB07)
Renseignements sur le brevet
Main patents have expired but secondary patents might remain active in some jurisdictions. For more information on specific patents and license status for developing countries visit www.MedsPal.org
Lire la suite sur les brevets.
Wikipédia
Tiotropium bromide
DrugBank
Tiotropium bromide (Tiotropium)
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the following changes to the listing of tiotropium on the EML: - update the listing description of inhalation delivery systems for consistency across the Model Lists and to better reflect product characteristics.